NEWSWIRETODAY Press Release& Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
More news: Health / Surgery
Written by / Agency / Source: Implantable Artificial Kidney Corporation
Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Dr. Ira Kurtz Joins Implantable Artificial Kidney Corp Advisory Board - Dr. Ira Kurtz will advise IAKC in research & development of the IAK-1 implantable artificial kidney - ImplantableKidney.com
Dr. Ira Kurtz Joins Implantable Artificial Kidney Corp Advisory Board

 

NewswireToday - /newswire/ - Tomball, TX, United States, 2014/10/16 - Dr. Ira Kurtz will advise IAKC in research & development of the IAK-1 implantable artificial kidney - ImplantableKidney.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health / Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

After a lengthy search, Dr. Ira Kurtz, Chief of the University of California, Los Angeles (UCLA) Division of Nephrology was invited to join the Advisory Board of the Implantable Artificial Kidney Corporation (IAKC). Dr. Kurtz will play an important role in advising IAKC in all aspects of the research and development of the IAK-1 implantable artificial kidney. Dr. Kurtz will assist IAKC to advance the development of the IAK-1 through all phases of laboratory and animal testing, and ultimately human trials, leading to approval of the IAK-1 by the FDA.

“Dr. Ira Kurtz brings years of experience, insight and knowledge to our project. He is a dedicated kidney doctor, research scientist, and professor with vast knowledge of the function of the human kidney. His background will prove instrumental in the further development of the IAK-1. We are very fortunate to have him involved”, said Roland G. Ludlow, IAKC’s CEO/President.

About Dr. Ira Kurtz, M.D., FRCP ©

Professor of Medicine, Chief of the Division of Nephrology at UCLA, Factor Chair in Molecular Nephrology

Dr. Kurtz is a board certified internist and nephrologist who has been practicing clinical nephrology for nearly 30 years. He is a graduate of the University of Toronto, and completed his postgraduate training at the University of California, San Francisco, and the National Institute of Health. Dr. Kurtz is a member of the American Society of Clinical Investigation, the American Physiological Society, the Biophysical Society, the American Society of Nephrology, and is a Fellow of the Royal College of Physicians and Surgeons of Canada. On faculty at UCLA since 1985, Dr. Kurtz has authored over 300 scientific publications, book chapters, and abstracts. He is on the editorial board of several journals and is a reviewer of major scientific publications.

About the Implantable Artificial Kidney Corporation (IAKC)

IAKC (implantablekidney.com) is solely involved in the research and development of a fully functional implantable artificial kidney. The company currently possess a patented prototype that is being further developed and tested.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health / Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Implantable Artificial Kidney Corporation

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Health / Surgery articles,
CATCH Visitors via Your Competitors Announcements!


Dr. Ira Kurtz Joins Implantable Artificial Kidney Corp Advisory Board

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
Publisher Contact: Roland Ludlow - ImplantableKidney.com 
1-888-234-7631 rludlow[.]implantablekidney.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Implantable Artificial Kidney Corporation securities in any jurisdiction including any other companies listed or named in this release.

Health / Surgery via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Implantable Artificial Kidney Corporation / Company Profile


Read Health / Surgery Most Recent Related Newswires:

Syapse Awarded 2021 Technology Innovation Leadership Award by Frost & Sullivan for Accelerating Real-world Care Delivery
Lumeon Commended by Frost & Sullivan for Enabling Digital Transformation in Healthcare
Payment Integrity Solutions Enable Healthcare Plans to Optimize Processes and Maximize Returns Finds Frost & Sullivan
Menopause to Become the Next Game-changer in the Global Femtech Solutions Industry by 2025 Finds Frost & Sullivan
Innovative MedTech Business Models Will Enable Cost-effective, Decentralized and Patient-centric Care Finds Frost & Sullivan
Data Monetization a Must for MedTech Industry to Evolve Toward Real-World Evidence and Precision Medicine Finds Frost & Sullivan
InterSystems Partners with Cognetivity on Ground-breaking AI Solution for Early Dementia Detection
Humimic Medical, Partners Team Up to Make A Difference in South Carolina COVID Battle
Adoption of HaH Model Surged Eight-fold with the Availability of Advanced Remote Monitoring and Digital Health Solutions Finds Frost & Sullivan
Major Innovation Announcement Planned, SC Life Sciences Conference Shatters Registration Record
South Carolina Life Sciences Conference Adds Top Executives from Microsoft, Alphabet, PhRMA
SC Life Sciences Conference to Feature BIO Global Executive February 16-17
20Lighter Announces Orthopedic Surgery Alliance
Calmerry Introduces Individual, Couples and Family Online Therapy with Licensed Professionals
CoverMyMeds Lauded by Frost & Sullivan for Seamlessly Connecting the Healthcare Network with its Industry-leading ePA Platform

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2022 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are proudly NOT affiliated with USA TODAY (usatoday.com)